Sage Therapeutics (NASDAQ:SAGE) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Sage Therapeutics missed estimated earnings by 1.47%, reporting an EPS of $-2.07 versus an estimate of $-2.04.

Revenue was down $1.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 5.59% increase in the share price the next day.

Here's a look at Sage Therapeutics's past performance:

To track all earnings releases for Sage Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.